Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance

被引：4
|
作者：
Llibre, J. M. [1 ,2 ,3 ]
Young, B. [4 ,5 ]
机构：
[1] Univ Hosp Germans Trias & Pujol, Lluita SIDA Fdn, Badalona 08916, Spain
[2] Univ Hosp Germans Trias & Pujol, HIV Unit, Badalona 08916, Spain
[3] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[4] Int Assoc Providers AIDS Care, Washington, DC USA
[5] Univ Denver, Josef Korbel Sch Int Studies, Denver, CO USA
来源：
HIV MEDICINE | 2014年 / 15卷 / 04期
关键词：
NAIVE HIV-1-INFECTED PATIENTS; RITONAVIR-BOOSTED ATAZANAVIR; DISOPROXIL FUMARATE; INITIAL TREATMENT; PLUS RITONAVIR; EFFICACY; COBICISTAT; TENOFOVIR; REGIMENS; SAFETY;
D O I：
10.1111/hiv.12109
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：193 / 195
页数：3
相关论文
共 50 条
  • [21] Assessment of Unplanned Treatment Interruptions During Modern Day Radiotherapy in a Large Patient Database
    Shahid, T.
    Sarkar, B.
    Mukherjee, M.
    Bhattacharya, J.
    Ghosh, T.
    De, A.
    Munshi, A.
    Ganesh, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E208 - E208
  • [22] Genetic Barrier to Resistance for Dolutegravir
    Llibre, Josep M.
    Pulido, Federico
    Garcia, Federico
    Garcia Deltoro, Miguel
    Blanco, Jose L.
    Delgado, Rafael
    AIDS REVIEWS, 2015, 17 (01) : 56 - 64
  • [23] The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance
    Goette, Matthias
    CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 644 - 650
  • [24] Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
    Ortiz, GM
    Wellons, M
    Brancato, J
    Vo, HTT
    Zinn, RL
    Clarkson, DE
    Van Loon, K
    Bonhoeffer, S
    Miralles, GD
    Montefiori, D
    Bartlett, JA
    Nixon, DF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) : 13288 - 13293
  • [25] Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions
    Bunupuradah, Torsak
    Duong, Trinh
    Compagnucci, Alexandra
    McMaster, Paddy
    Bernardi, Stefania
    Kanjanavanit, Suparat
    Rampon, Osvalda
    Faye, Albert
    Saidi, Yacine
    Riault, Yoann
    De Rossi, Anita
    Klein, Nigel
    Ananworanich, Jintanat
    Gibb, Diana
    AIDS, 2013, 27 (04) : 579 - 589
  • [26] Antiretroviral Treatment Interruptions Induced by the Kenyan Postelection Crisis Are Associated With Virological Failure
    Mann, Marita
    Diero, Lameck
    Kemboi, Emmanuel
    Mambo, Fidelis
    Rono, Mary
    Injera, Wilfred
    Delong, Allison
    Schreier, Leeann
    Kaloustian, Kara W.
    Sidle, John
    Buziba, Nathan
    Kantor, Rami
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (02) : 220 - 224
  • [27] Drug resistance mutations during structured treatment interruptions
    Yerly, S
    Fagard, C
    Günthard, HF
    Hirschel, B
    Perrin, L
    ANTIVIRAL THERAPY, 2003, 8 (05) : 411 - 415
  • [28] The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    van de Vijver, DA
    Wensing, AMJ
    Angarano, G
    Åsjö, B
    Balotta, C
    Boeri, E
    Camacho, R
    Chaix, ML
    Costagliola, D
    De Luca, A
    Derdelinckx, I
    Grossman, Z
    Hamouda, O
    Hatzakis, A
    Hemmer, R
    Hoepelman, A
    Horban, A
    Korn, K
    Kücherer, C
    Leitner, T
    Loveday, C
    MacRae, E
    Maljkovic, I
    de Mendoza, C
    Meyer, L
    Nielsen, C
    de Coul, ELMO
    Ormaasen, V
    Paraskevis, D
    Perrin, L
    Puchhammer-Stöckl, E
    Ruiz, L
    Salminen, M
    Schmit, JC
    Schneider, F
    Schuurman, R
    Soriano, V
    Stanczak, G
    Stanojevic, M
    Vandamme, AM
    Van Laethem, K
    Violin, M
    Wilbe, K
    Yerly, S
    Zazzi, M
    Boucher, CAB
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 352 - 360
  • [29] Drug resistance and antiretroviral drug development
    Shafer, RW
    Schapiro, JM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 817 - 820
  • [30] Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment
    Mulato, Andrew
    Acosta, Rima
    Chang, Silvia
    Martin, Ross
    Yant, Stephen R.
    Cihlar, Tomas
    White, Kirsten
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 86 (03) : 369 - 377
12345